Biotensidon is a stock company located in Switzerland. It has a research and technical facility in Germany that seeks to develop biotechnological methods using microorganisms to produce industrial biological raw materials. The Biotensidon Team consists of experts from all fields of biology, biochemistry as well as biotechnology.
Biotensidon was a finalist in Germany’s prestigious Next Economy Award 2016, in recognition of its ground-breaking research on the industrial application of environmentally-sound bio-agents. Biotensidon is the first company to achieve a reliable and effective fermentation process for the patented supramolecular complexes “Rhapynal®”. This contributes to creating stability in the production on an industrial scale. On the basis of this innovative technology, Biotensidon continues the research on the production process and also on the reduction of production cost.